EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Continuous Pyruvate Supplementation Enhances Neuroprotective Resilience Against Kainate-Induced Status Epilepticus Through Metabolic Preconditioning

Yong Jae Cho, Soo Jin Lee, Yuna Kim, Yeeun Kim, Seog-Young Kim iD, Kyunggon Kim, Dong-Cheol Woo iD, Hyun Ju Yoo iD, Joo-Yong Lee iD

Biomolecules · 29.05.2026 · 16 (6) · 805

DOI: 10.3390/biom16060805 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 29.05.2026. Verfasst von Yong Jae Cho und 8 weiteren Autor:innen. Beteiligte Einrichtung: Asan Institute for Life Sciences, Asan Medical Center, Seoul 05505, Republic of Korea. Hauptthemen laut MEDLINE: Status Epilepticus, Kainic Acid, Pyruvic Acid, Neuroprotective Agents. Die Arbeit nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Asan Institute for Life Sciences, Asan Medical Center, Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Refractory status epilepticus refers to persistent and recurrent seizures unresponsive to medication, often leading to neuronal injury and neurobehavioral deficits. Studies have demonstrated that intraperitoneal bolus administration of pyruvate attenuates neuronal damage in rodent models of chemically induced status epilepticus (SE), while the precise neuroprotective mechanism remains to be further explored. This study investigated the neuroprotective effects of long-term supplementation with exogenous pyruvate against SE. When male C57BL/6 mice received 3% sodium pyruvate (SP) in the drinking water ad libitum for 20 weeks, they exhibited elevated levels of essential neurochemicals and energy metabolites in the brain compared to the control mice that received the equimolar saline solution. Following the intraperitoneal administration of kainate (KA) to induce severe SE, the SP-fed mice showed enhanced resistance to seizure activity, reduced neuronal injury, and improved neurobehavioral performance compared to the saline-fed mice. Regarding the molecular mechanisms underlying their neuroprotective properties, the levels of pyruvate metabolism-mediating proteins, neuronal and synaptic proteins, and neuroprotective proteins remained upregulated in the brains of the SP-fed mice following KA-induced SE. Conversely, the levels of pro-apoptotic and oxidative stress markers were suppressed. Collectively, this study indicates that long-term pyruvate supplementation may sustainably augment neurochemical and energy metabolism in the normal brain, thereby eliciting intrinsic neuroprotective properties. These effects contribute to preventing or ameliorating seizure activity, neuronal damage, and neurobehavioral deficits in mice following KA-induced SE, suggesting its prophylactic or therapeutic potential against epileptic seizures and SE through metabolic preconditioning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Status EpilepticusKainic AcidPyruvic AcidNeuroprotective AgentsAnimalsMaleMiceMice, Inbred C57BLOxidative StressBrainEnergy MetabolismNeuronsDisease Models, Animal

Stichwörter der Autor:innen

epileptic seizuresepileptogenesisneurobehavioral comorbidityneurochemical or energy metabolismprophylaxissodium pyruvate

Substanzen

Kainic AcidPyruvic AcidNeuroprotective Agents

Autor:innen und Institutionen

  • Asan Institute for Life Sciences, Asan Medical Center, Seoul 05505, Republic of Korea.
  • Department of Medical Science, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
  • Department of Convergence Medicine, Asan Medical Center, Seoul 05505, Republic of Korea.
  • Department of Digital Medicine, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
  • Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.

ORCID-Profile: Seog-Young Kim, Dong-Cheol Woo, Hyun Ju Yoo, Joo-Yong Lee

Förderung

  • National Research Foundation of Korea
  • Asan Institute for Life Sciences, Asan Medical Center
  • Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea

Zitieren

APA

Cho, Y. J., Lee, S. J., Kim, Y., Kim, Y., Kim, S. Y., Kim, K., Woo, D. C., Yoo, H. J., & Lee, J. Y. (2026). Continuous Pyruvate Supplementation Enhances Neuroprotective Resilience Against Kainate-Induced Status Epilepticus Through Metabolic Preconditioning. Biomolecules, 16(6), 805. https://doi.org/10.3390/biom16060805

Vancouver

Cho YJ, Lee SJ, Kim Y, Kim Y, Kim SY, Kim K, et al. Continuous Pyruvate Supplementation Enhances Neuroprotective Resilience Against Kainate-Induced Status Epilepticus Through Metabolic Preconditioning. Biomolecules. 2026;16(6):805. doi:10.3390/biom16060805

BibTeX
@article{Cho2026,
  author = {Cho, Yong Jae and Lee, Soo Jin and Kim, Yuna and Kim, Yeeun and Kim, Seog-Young and Kim, Kyunggon and Woo, Dong-Cheol and Yoo, Hyun Ju and Lee, Joo-Yong},
  title = {Continuous Pyruvate Supplementation Enhances Neuroprotective Resilience Against Kainate-Induced Status Epilepticus Through Metabolic Preconditioning},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {6},
  pages = {805},
  doi = {10.3390/biom16060805}
}
Kostenlos starten →